Metallo-β-lactamase and genetic diversity of pseudomonas aeruginosa in intensive care units in Campo Grande, MS, Brazil

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 3, 2011, Pages 195-199

  Rodrigues, Ana Claudia Souza ^a   Chang, Marilene Rodrigues ^a   Nóbrega, Gabriela Dorn ^a   Rodrigues, Mayara Souza ^a   Carvalho, Nadia Cristina Pereira ^a   Gomes, Beatriz Garcia ^b   de Almeida, Dênio Lopes ^a   Carvalho, Karyne Rangel ^a   Asensi, Marise Dutra ^c  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b Hospital Regional de Mato Grosso do Sul   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Beta lactamases; Drug resistance; Electrophoresis; Gel; Multiple; Pseudomonas aeruginosa; Pulsed field

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRAZIL; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC VARIABILITY; INTENSIVE CARE UNIT; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY SYSTEM; URINARY TRACT;

EID: 79959584382     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70174-X     Document Type: Article

References (27)

1. Agodi A, Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C. Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients. Intensive Care Med 2007; 33(7):1155-61.
2. Zavascki AP, Barth AL, Goncalves AL et al. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 2006; 58(2):387-92.
3. Gales AC, Menezes LC, Silbert S, Sader HS. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. J Antimicrob Chemother 2003; 52(4):699-702.
4. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34(5):634-40.
5. Pitout JD, Chow BL, Gregson DB, Laupland KB, Elsayed S, Church DL. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. J Clin Microbiol 2007; 45(2):294-8.
6. Yong D, Choi YS, Roh KH et al. Increasing prevalence and diversity of metallo-beta-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea. Antimicrob Agents Chemother 2006; 50(5):1884-6.
7. Gilardi GL. Practical schema for the identification of nonfermentative gram negative bacteria encountered in medical bacteriology. Am J Med Technol 1972; 38(3):65-72.
8. CLSI. Clinical Laboratory Standard of Institute. Performance standards for antimicrobial susceptibility testing 2007; M100-S17.
9. Arakawa Y, Shibata N, Shibayama K et al. Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000; 38(1):40-3.
10. Picao RC, Andrade SS, Nicoletti AG et al. Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol 2008; 46(6):2028-37.
11. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol 1986; 51 Pt 1:263-73.
12. Kimura S, Alba J, Shiroto K et al. Clonal diversity of metallo-beta-lactamase-possessing Pseudomonas aeruginosa in geographically diverse regions of Japan. J Clin Microbiol 2005; 43(1):458-61.
13. Jeong SH, Bae IK, Park KO et al. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J Microbiol 2006;44(4):423-31.
14. Romao CM, Faria YN, Pereira LR, Asensi MD. Susceptibility of clinical isolates of multiresistant Pseudomonas aeruginosa to a hospital disinfectant and molecular typing. Mem Inst Oswaldo Cruz 2005; 100(5):541-8.
15. Chang MR, Carvalho NC, Oliveira AL, Moncada PM, Moraes BA, Asensi MD. Surveillance of pediatric infections in a teaching hospital in Mato Grosso do Sul, Brazil. Braz J Infect Dis. 2003; 7(2):149-60.
16. Lodise TP, Miller CD, Graves J et al. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob Agents Chemother 2007; 51(2):417-22.
17. Zavascki AP, Barth AL, Fernandes JF, Moro AL, Goncalves AL, Goldani LZ. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study. Crit Care 2006; 10(4):R114.
18. Sader HS, Gales AC, Pfaller MA et al. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis 2001; 5(4):200-14.
19. Furtado GH, Martins ST, Machado AM, Wey SB, Medeiros EA. Clinical culture surveillance of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter species in a teaching hospital in Sao Paulo, Brazil: a 7-year study. Infect Control Hosp Epidemiol 2006; 27(11):1270-3.
20. Raja NS, Singh NN. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. J Microbiol Immunol Infect 2007; 40(1):45-9.
21. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 1999; 33(9):960-7.
22. Aubert D, Poirel L, Chevalier J, Leotard S, Pages JM, Nordmann P. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001; 45(6):1615-20.
23. Giakkoupi P, Petrikkos G, Tzouvelekis LS, Tsonas S, Legakis NJ, Vatopoulos AC. Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals. J Clin Microbiol 2003; 41(2):822-5.
24. Graf T, Fuentefria DB, Corcao G. [Occurrence of multire-sistant strains of Pseudomonas aeruginosa producing metallo-beta-lactamase blaSPM-1 in clinical samples]. Rev Soc Bras Med Trop 2008; 41(3):306-8.
25. Carvalho AP, Albano RM, de Oliveira DN, Cidade DA, Teixeira LM, Marques Ede A. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-beta-lactamase in a hospital located in Rio de Janeiro, Brazil. Microb Drug Resist 2006; 12(2):103-8.
26. Goncalves DC, Lima AB, Leao LS, Filho JR, Pimenta FC, Vieira JD. [Detection of metallo-beta-lactamase in Pseudomonas aeruginosa isolated from hospitalized patients in Goiania, State of Goias]. Rev Soc Bras Med Trop. 2009; 42(4):411-4.
27. Figueiredo-Mendes CM, Sinto S, Mello-Sampaio JL et al. Pseudomonas aeruginosa clonal dissemination in Brazilian intensive care units. Enferm Infecc Microbiol Clin. 2005; 23(7):402-5.